Literature DB >> 1989154

Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.

C C Küchle1, G H Thoenes, K H Langer, H U Schorlemmer, R R Bartlett, R Schleyerbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1989154

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.

Authors:  C Rastellini; L Cicalese; R Leach; M Braun; J J Fung; T E Starzl; A S Rao
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

Review 2.  Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.

Authors:  R R Bartlett; M Dimitrijevic; T Mattar; T Zielinski; T Germann; E Rüde; G H Thoenes; C C Küchle; H U Schorlemmer; E Bremer
Journal:  Agents Actions       Date:  1991-01

Review 3.  Xenobiotics, chimerism and the induction of tolerance following organ transplantation.

Authors:  C P Delaney; A W Thomson; A J Demetris; T E Starzl
Journal:  Ther Immunol       Date:  1994-06

4.  Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?

Authors:  T Zielinski; D Zeitter; S Müller; R R Bartlett
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 5.  Effects of leflunomide on immune responses and models of inflammation.

Authors:  R R Bartlett; H Anagnostopulos; T Zielinski; T Mattar; R Schleyerbach
Journal:  Springer Semin Immunopathol       Date:  1993

Review 6.  Leflunomide: mode of action in the treatment of rheumatoid arthritis.

Authors:  F C Breedveld; J M Dayer
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

7.  Effects of leflunomide on inflamation and fibrosis in bleomycine induced pulmonary fibrosis in wistar albino rats.

Authors:  Servet Kayhan; Aygul Guzel; Latif Duran; Serife Tutuncu; Ahmet Guzel; Mithat Gunaydın; Osman Salis; Ali Okuyucu; Mustafa Yasin Selcuk
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 8.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

9.  Leflunomide therapy following penetrating keratoplasty in the rat.

Authors:  S E Coupland; S Klebe; A C Karow; L Krause; H Kruse; R R Bartlett; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

10.  Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide.

Authors:  C Mrowka; G H Thoenes; K H Langer; R R Bartlett
Journal:  Ann Hematol       Date:  1994-04       Impact factor: 3.673
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.